Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001834913-25-000006·Quoin Pharmaceuticals, Ltd.
Schedule 13G ownership disclosure
QUOIN PHARMACEUTICALS LTD
American Depositary Shares, Each representing thirty-five(35) ordinary shares, no par value per share · CUSIP: 74907L409
Event date: 2025-10-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Resolute Capital Asset Partners LLC
Shares: 50,000.00 · Class: 8.5%
- Resolute Capital Asset Partners Fund I LP
Shares: 50,000.00 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001834913-25-000006
- Form type
- SCHEDULE 13G
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Dec 11, 2025
- Reporting period
- Oct 10, 2025
- Description
- Schedule 13G beneficial ownership